(Q54183886)

26 May 2018

title

Synergy of fluconazole with macrophages for antifungal activity against Candida albicans. (English)

1 reference

26 May 2018

1 reference

1 reference

U K Garcha

1

1 reference

26 May 2018

E Brummer

series ordinal

2

1 reference

26 May 2018

D A Stevens

series ordinal

3

1 reference

26 May 2018

publication date

1 January 1995

1 reference

26 May 2018

number of pages

6

1 reference

inferred from page(s)

published in

Mycopathologia

1 reference

26 May 2018

volume

132

1 reference

26 May 2018

issue

3

1 reference

26 May 2018

page(s)

123-128

1 reference

26 May 2018

https://scigraph.springernature.com/pub.10.1007/bf01103976

exact match

0 references

cites work

Overview of medically important antifungal azole derivatives

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01103976

Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01103976

Macrophage colony-stimulating factor induction of enhanced macrophage anticryptococcal activity: synergy with fluconazole for killing.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01103976

Systemic candidiasis in mice. II.--Main role of polymorphonuclear leukocytes in resistance to infection

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Evidence for macrophage-mediated protection against lethal Candida albicans infection.

1 reference

12 December 2020

Chronic systemic candidiasis

1 reference

12 December 2020

Treatment and prevention of oropharyngeal candidiasis

1 reference

12 December 2020

Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi

1 reference

12 December 2020

Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or gamma-interferon

1 reference

12 December 2020

In vitro phagocytosis of Candida albicans by peritoneal mouse macrophages

1 reference

12 December 2020

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality

1 reference

12 December 2020

Immunity to Candida albicans

1 reference

12 December 2020

Role of activated macrophages in resistance to systemic candidosis

1 reference

12 December 2020

Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome

1 reference

12 December 2020

Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro

1 reference

12 December 2020

Efficacy of granulocyte transfusions in the control of systemic candidiasis in the leukopenic host

1 reference

12 December 2020

Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages

1 reference

12 December 2020

Candidiasis in the transplant patient.

1 reference

12 December 2020

Interaction of fluconazole and human phagocytic cells. Uptake of the antifungal agent and its effects on the survival of ingested fungi in phagocytes

1 reference

12 December 2020

Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01103976

1 reference

26 May 2018

1 reference

26 May 2018